| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |